Guangsen Zhang
Overview
Explore the profile of Guangsen Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiao X, Xie R, Zhang Y, Yin Y, Chen Y, Sun N, et al.
Biochim Biophys Acta Mol Basis Dis
. 2025 Mar;
1871(5):167765.
PMID: 40044065
Background: Inherited thrombocytopenias (ITs) are a group of heterogeneous diseases characterized by low platelet counts and bleeding diathesis. ITs are primarily caused by mutations in genes involved in megakaryocyte differentiation,...
2.
Tang D, Wang H, Jiang Y, Chen M, Zhang G, Wu S, et al.
PLoS One
. 2024 Dec;
19(12):e0316109.
PMID: 39715205
Aims: Acute promyelocytic leukemia (APL) progresses quickly and often leads to early hemorrhagic death. Treatment with all-trans retinoic acid (ATRA) promotes differentiation of APL cells and clinical remission, making APL...
3.
Zhou X, Chen X, Chen J, Wen L, Zhang Z, Qin Y, et al.
Blood
. 2024 Jul;
144(14):1471-1485.
PMID: 39046762
Atypical acute promyelocytic leukemia (aAPL) presents a complex landscape of retinoic acid receptor (RAR) fusion genes beyond the well-known PML::RARA fusion. Among these, 31 individually rare RARA and RARG fusion...
4.
Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al.
PLoS One
. 2023 Nov;
18(11):e0294236.
PMID: 37943830
Graphics are widely used to provide summarization of complex data in scientific publications. Although there are many tools available for drawing graphics, their use is limited by programming skills, costs,...
5.
Yin L, Zhang Q, Xie S, Cheng Z, Li R, Zhu H, et al.
Hum Cell
. 2023 May;
36(4):1564-1577.
PMID: 37222919
Currently, therapy for Chronic Myeloid Leukemia (CML) patients with the T315I mutation is a major challenge in clinical practice due to its high degree of resistance to first- and second-generation...
6.
Wang J, Peng H, Zhang G, Yan W
Hematology
. 2023 May;
28(1):2198862.
PMID: 37199349
Background: Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. We aimed to build a ferroptosis-related gene (FRG) prognostic signature to predict the outcome of DLBCLs. Methods: Our study...
7.
Deng M, Yuan H, Peng H, Liu S, Xiao X, Wang Z, et al.
Curr Cancer Drug Targets
. 2023 Mar;
23(8):643-652.
PMID: 36927430
Background: LINC00461 has been implicated to be involved in several types of cancer while its roles in multiple myeloma remain unclear. Our study aims to investigate the roles of LINC00461...
8.
Aini W, Xie L, Hu W, Tang Y, Peng H, Zhang G, et al.
Front Genet
. 2023 Mar;
14:1139351.
PMID: 36873934
Polycythemia Vera (PV) is a type of typical Myeloproliferative Neoplasms (MPNs) characterized with excessive erythropoiesis and thrombosis. Anoikis is a special programmed cell death mode induced by the adhesion disorder...
9.
Li J, Zhang Y, Li J, Xu Y, Zhang G
Haematologica
. 2022 Oct;
108(2):627-632.
PMID: 36300779
No abstract available.
10.
Zhu S, Xing C, Zhang G, Peng H, Wang Z
Bioorg Chem
. 2022 Oct;
129:106217.
PMID: 36283176
Background: Multiple myeloma (MM) is a hematological malignancy of plasma cells characterized by the production of monoclonal immunoglobulin protein. Despite significant advances in the treatment of MM, it remains an...